IMARC Group has recently released a new research study titled “United States Prefilled Syringes Market Report by Design (Single-Chamber Prefilled Syringes, Dual-Chamber Prefilled Syringes, Customized Prefilled Syringes), Material (Glass Prefilled Syringes, Plastic Prefilled Syringes), Closing System (Staked Needle System, Luer Cone System, Luer Lock Form System), Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis, Oncology, and Others), End User (Hospitals, Clinics, and Others), and Region 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
United States Prefilled Syringes Market Overview
The United States prefilled syringes market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 10.64% during 2025-2033.
Market Size and Growth
Base Year: 2024
Forecast Years: 2025-2033
Historical Years: 2019-2024
Market Size in 2024: USD 86.9 Billion
Market Forecast in 2033: USD 141.8 Billion
Market Growth Rate (2025-2033): 5.17%
Request for a sample copy of the report: https://www.imarcgroup.com/united-states-prefilled-syringes-market/requestsample
Key Market Highlights:
✔️ Strong growth driven by rising demand for convenient and accurate drug delivery systems
✔️ Increasing adoption of biologics and self-administration therapies boosting market expansion
✔️ Growing preference for disposable and safety-engineered syringe designs to reduce contamination risks
✔️ Technological advancements enhancing material durability and product efficiency
✔️ Expanding use of prefilled syringes across hospitals, homecare, and specialty clinics
United States Prefilled Syringes Market Trends and Drivers:
The U.S. prefilled syringes market is witnessing an outstanding transformation with the introduction of innovative technology in drug delivery devices and increasing preference for prefilled syringes for their ease of use, minimized risk of contamination, and administration of accurate doses of drug. The convenience, safety and ease of use of prefilled syringes has increased interest from both healthcare providers and patients. This is especially true when treating chronic disease processes where the patient must self administer and be compliant with a treatment regimen.
In terms of revenue, the prefilled syringes market in the U.S. is estimated to have a meaningful growth over the next few years, mainly due to the growth of various drug classes such as oncology, immunology, multiple sclerosis (MS), diabetes, inflammatory diseases, and others, and estimated to reach an important market size by 2025. The prevalence of chronic diseases coupled with the increasing prevalence of personalized medicines and development of new formulations are propelling the growth of the prefilled syringes market, as healthcare professionals and patients prefer the use of prefilled syringes in modern healthcare over customary drug delivery methods.
The US prefilled syringe market is characterized by the presence of several key companies that have invested heavily in the research and development of their prefilled syringe portfolios, as well as other prefilled syringe technologies. By 2025, these companies' market share will likely be influenced by their ability to bring innovation and change in light of shifting demands from the industry, healthcare providers and patients. Startups continue to also enter the syringe market with other products such as customized solutions and smart syringes that are competitive alternatives.
Furthermore, key factors driving the growth of the U.S. prefilled syringes market in the near future include a shift toward patient-centricity in the healthcare sector and an increased need for self-injection devices. Other factors increasing the market include support from the regulatory bodies for the adoption of drug delivery technologies and increasing investments in healthcare infrastructure. Connected devices will monitor and provide feedback on prefilled syringe usage by 2025, providing patient adherence benefits and stimulating innovative development in the drug delivery space to improve patient safety and product design.
United States Prefilled Syringes Market Segmentation:
The market report segments the market based on product type, distribution channel, and region:
Design Insights:
- Single-Chamber Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Customized Prefilled Syringes
Material Insights:
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
Closing System Insights:
- Staked Needle System
- Luer Cone System
- Luer Lock Form System
Application Insights:
- Diabetes
- Anaphylaxis
- Rheumatoid Arthritis
- Oncology
- Others
End User Insights:
- Hospitals
- Clinics
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Speak to An Analyst: https://www.imarcgroup.com/request?type=reportid=20014flag=C
Competitive Landscape:
The market research report offers an in-depth analysis of the competitive landscape, covering market structure, key player positioning, top winning strategies, a competitive dashboard, and a company evaluation quadrant. Additionally, detailed profiles of all major companies are included.
Key Highlights of the Report
- Market Performance (2019-2024)
2. Market Outlook (2025-2033)
3. COVID-19 Impact on the Market
4. Porter’s Five Forces Analysis
5. Strategic Recommendations
6. Historical, Current and Future Market Trends
7. Market Drivers and Success Factors
8. SWOT Analysis
9. Structure of the Market
10. Value Chain Analysis
11. Comprehensive Mapping of the Competitive Landscape
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
